Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Structure of McsB, a protein kinase for regulated arginine phosphorylation.

Suskiewicz MJ, Hajdusits B, Beveridge R, Heuck A, Vu LD, Kurzbauer R, Hauer K, Thoeny V, Rumpel K, Mechtler K, Meinhart A, Clausen T.

Nat Chem Biol. 2019 May;15(5):510-518. doi: 10.1038/s41589-019-0265-y. Epub 2019 Apr 8.

PMID:
30962626
2.

Neurogaming With Motion-Onset Visual Evoked Potentials (mVEPs): Adults Versus Teenagers.

Beveridge R, Wilson S, Callaghan M, Coyle D.

IEEE Trans Neural Syst Rehabil Eng. 2019 Apr;27(4):572-581. doi: 10.1109/TNSRE.2019.2904260. Epub 2019 Mar 11.

PMID:
30869627
3.

Ion Mobility Mass Spectrometry Uncovers the Impact of the Patterning of Oppositely Charged Residues on the Conformational Distributions of Intrinsically Disordered Proteins.

Beveridge R, Migas LG, Das RK, Pappu RV, Kriwacki RW, Barran PE.

J Am Chem Soc. 2019 Mar 27;141(12):4908-4918. doi: 10.1021/jacs.8b13483. Epub 2019 Mar 12.

4.

Ion Mobility Mass Spectrometry Measures the Conformational Landscape of p27 and its Domains and how this is Modulated upon Interaction with Cdk2/cyclin A.

Beveridge R, Migas LG, Kriwacki RW, Barran PE.

Angew Chem Int Ed Engl. 2019 Mar 4;58(10):3114-3118. doi: 10.1002/anie.201812697. Epub 2019 Jan 24.

PMID:
30570821
5.

Reply to 'Defining distance restraints in HADDOCK'.

Orbán-Németh Z, Beveridge R, Hollenstein DM, Rampler E, Stranzl T, Hudecz O, Doblmann J, Schlögelhofer P, Mechtler K.

Nat Protoc. 2018 Jul;13(7):1503-1505. doi: 10.1038/s41596-018-0018-5. No abstract available.

PMID:
29942006
6.

Author Correction: Structural prediction of protein models using distance restraints derived from cross-linking mass spectrometry data.

Orbán-Németh Z, Beveridge R, Hollenstein DM, Rampler E, Stranzl T, Hudecz O, Doblmann J, Schlögelhofer P, Mechtler K.

Nat Protoc. 2018 Jul;13(7):1724. doi: 10.1038/s41596-018-0024-7.

PMID:
29942004
7.

The replicative helicase MCM recruits cohesin acetyltransferase ESCO2 to mediate centromeric sister chromatid cohesion.

Ivanov MP, Ladurner R, Poser I, Beveridge R, Rampler E, Hudecz O, Novatchkova M, Hériché JK, Wutz G, van der Lelij P, Kreidl E, Hutchins JR, Axelsson-Ekker H, Ellenberg J, Hyman AA, Mechtler K, Peters JM.

EMBO J. 2018 Aug 1;37(15). pii: e97150. doi: 10.15252/embj.201797150. Epub 2018 Jun 21.

PMID:
29930102
8.

UCHL3 Regulates Topoisomerase-Induced Chromosomal Break Repair by Controlling TDP1 Proteostasis.

Liao C, Beveridge R, Hudson JJR, Parker JD, Chiang SC, Ray S, Ashour ME, Sudbery I, Dickman MJ, El-Khamisy SF.

Cell Rep. 2018 Jun 12;23(11):3352-3365. doi: 10.1016/j.celrep.2018.05.033.

9.

Structural prediction of protein models using distance restraints derived from cross-linking mass spectrometry data.

Orbán-Németh Z, Beveridge R, Hollenstein DM, Rampler E, Stranzl T, Hudecz O, Doblmann J, Schlögelhofer P, Mechtler K.

Nat Protoc. 2018 Mar;13(3):478-494. doi: 10.1038/nprot.2017.146. Epub 2018 Feb 8. Erratum in: Nat Protoc. 2018 Jul;13(7):1724.

10.

Does a Free Office Visit Affect Primary Care-Seeking Behavior? A Study of New Exchange Health Plan Enrollees in Mississippi.

Beech BM, Cordier T, Happe LE, Trunk L, Haugh GS, Kwong R, Gopal V, Beveridge RA.

Am Health Drug Benefits. 2017 Apr;10(2):64-71.

11.

Mortality Differences Between Traditional Medicare and Medicare Advantage: A Risk-Adjusted Assessment Using Claims Data.

Beveridge RA, Mendes SM, Caplan A, Rogstad TL, Olson V, Williams MC, McRae JM, Vargas S.

Inquiry. 2017 Jan 1;54:46958017709103. doi: 10.1177/0046958017709103.

12.

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, Basso U, Blay JY, Tendero O, Beveridge RD, Ferraresi V, Lugowska I, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Palmerini E, De Sanctis R, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Casali PG.

Lancet Oncol. 2017 Jun;18(6):812-822. doi: 10.1016/S1470-2045(17)30334-0. Epub 2017 May 9. Erratum in: Lancet Oncol. 2017 Jun;18(6):e301.

PMID:
28499583
13.

Family Physician Readiness for Value-Based Payments: Does Ownership Status Matter?

Robertson-Cooper H, Neaderhiser B, Happe LE, Beveridge RA.

Popul Health Manag. 2017 Oct;20(5):357-361. doi: 10.1089/pop.2016.0135. Epub 2017 Jan 18.

14.

SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016).

Poveda A, Martinez V, Serrano C, Sevilla I, Lecumberri MJ, de Beveridge RD, Estival A, Vicente D, Rubió J, Martin-Broto J.

Clin Transl Oncol. 2016 Dec;18(12):1221-1228. doi: 10.1007/s12094-016-1579-9. Epub 2016 Nov 28.

15.

The bornavirus-derived human protein EBLN1 promotes efficient cell cycle transit, microtubule organisation and genome stability.

Myers KN, Barone G, Ganesh A, Staples CJ, Howard AE, Beveridge RD, Maslen S, Skehel JM, Collis SJ.

Sci Rep. 2016 Oct 14;6:35548. doi: 10.1038/srep35548.

16.

The physician-insurer dynamic must shift to successfully implement value-based payments.

Beveridge RA, Happe LE, Funk M.

Healthc (Amst). 2016 Dec;4(4):282-284. doi: 10.1016/j.hjdsi.2016.06.004. Epub 2016 Sep 3.

17.

3D graphics, virtual reality, and motion-onset visual evoked potentials in neurogaming.

Beveridge R, Wilson S, Coyle D.

Prog Brain Res. 2016;228:329-53. doi: 10.1016/bs.pbr.2016.06.006. Epub 2016 Jul 12.

PMID:
27590974
18.
19.

MRNIP/C5orf45 Interacts with the MRN Complex and Contributes to the DNA Damage Response.

Staples CJ, Barone G, Myers KN, Ganesh A, Gibbs-Seymour I, Patil AA, Beveridge RD, Daye C, Beniston R, Maslen S, Ahel I, Skehel JM, Collis SJ.

Cell Rep. 2016 Sep 6;16(10):2565-2575. doi: 10.1016/j.celrep.2016.07.087. Epub 2016 Aug 25.

20.

Mass spectrometry locates local and allosteric conformational changes that occur on cofactor binding.

Beveridge R, Migas LG, Payne KAP, Scrutton NS, Leys D, Barran PE.

Nat Commun. 2016 Jul 15;7:12163. doi: 10.1038/ncomms12163.

21.

Are we collectively ready to support physicians' journey to value-based care?

Filer W, Beveridge R.

Mod Healthc. 2016 Jan 11;46(2):25. No abstract available.

PMID:
27089625
22.

The path to value through the use of holistic care.

Beveridge RA.

Am J Manag Care. 2015 Oct;21(10):674b-c. No abstract available.

23.

New cofactor supports α,β-unsaturated acid decarboxylation via 1,3-dipolar cycloaddition.

Payne KA, White MD, Fisher K, Khara B, Bailey SS, Parker D, Rattray NJ, Trivedi DK, Goodacre R, Beveridge R, Barran P, Rigby SE, Scrutton NS, Hay S, Leys D.

Nature. 2015 Jun 25;522(7557):497-501. doi: 10.1038/nature14560. Epub 2015 Jun 17.

24.

Cost differential by site of service for cancer patients receiving chemotherapy.

Hayes J, Hoverman RJ, Brow ME, Dilbeck DC, Verrilli DK, Garey J, Espirito JL, Cardona J, Beveridge R.

Am J Manag Care. 2015 Mar 1;21(3):e189-96.

25.

Relating gas phase to solution conformations: Lessons from disordered proteins.

Beveridge R, Phillips AS, Denbigh L, Saleem HM, MacPhee CE, Barran PE.

Proteomics. 2015 Aug;15(16):2872-83. doi: 10.1002/pmic.201400605. Epub 2015 Jun 5.

26.

Evaluation and synthesis of polar aryl- and heteroaryl spiroazetidine-piperidine acetamides as ghrelin inverse agonists.

Orr ST, Beveridge R, Bhattacharya SK, Cameron KO, Coffey S, Fernando D, Hepworth D, Jackson MV, Khot V, Kosa R, Lapham K, Loria PM, McClure KF, Patel J, Rose C, Saenz J, Stock IA, Storer G, von Volkenburg M, Vrieze D, Wang G, Xiao J, Zhang Y.

ACS Med Chem Lett. 2014 Dec 14;6(2):156-61. doi: 10.1021/ml500414n. eCollection 2015 Feb 12.

27.

The leukemia-associated Rho guanine nucleotide exchange factor LARG is required for efficient replication stress signaling.

Beveridge RD, Staples CJ, Patil AA, Myers KN, Maslen S, Skehel JM, Boulton SJ, Collis SJ.

Cell Cycle. 2014;13(21):3450-9. doi: 10.4161/15384101.2014.956529.

28.

A mass-spectrometry-based framework to define the extent of disorder in proteins.

Beveridge R, Covill S, Pacholarz KJ, Kalapothakis JM, MacPhee CE, Barran PE.

Anal Chem. 2014 Nov 18;86(22):10979-91. doi: 10.1021/ac5027435. Epub 2014 Oct 29.

PMID:
25353392
29.

FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents.

Patil AA, Sayal P, Depondt ML, Beveridge RD, Roylance A, Kriplani DH, Myers KN, Cox A, Jellinek D, Fernando M, Carroll TA, Collis SJ.

Oncotarget. 2014 Aug 15;5(15):6414-24.

30.

A conversation with Roy A. Beveridge, MD. Quality, accountability, and leadership.

Beveridge RA.

Manag Care. 2014 May;23(5):42-5. No abstract available.

31.

Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate.

Bhattacharya SK, Andrews K, Beveridge R, Cameron KO, Chen C, Dunn M, Fernando D, Gao H, Hepworth D, Jackson VM, Khot V, Kong J, Kosa RE, Lapham K, Loria PM, Londregan AT, McClure KF, Orr ST, Patel J, Rose C, Saenz J, Stock IA, Storer G, VanVolkenburg M, Vrieze D, Wang G, Xiao J, Zhang Y.

ACS Med Chem Lett. 2014 Feb 24;5(5):474-9. doi: 10.1021/ml400473x. eCollection 2014 May 8.

32.

Ccdc13 is a novel human centriolar satellite protein required for ciliogenesis and genome stability.

Staples CJ, Myers KN, Beveridge RD, Patil AA, Howard AE, Barone G, Lee AJ, Swanton C, Howell M, Maslen S, Skehel JM, Boulton SJ, Collis SJ.

J Cell Sci. 2014 Jul 1;127(Pt 13):2910-9. doi: 10.1242/jcs.147785. Epub 2014 May 9.

33.

Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience.

Imedio ER, Beveridge RD, Urtasun JA, Campos GB, Estellés DL, Esparcia MF, Daroqui JC, Huerta ÁS, Ortiz AG, Salcedo JM.

Med Oncol. 2014 May;31(5):948. doi: 10.1007/s12032-014-0948-x. Epub 2014 Apr 17.

PMID:
24740650
34.

An organotrifluoroborate-based convergent total synthesis of the potent cancer cell growth inhibitory depsipeptides kitastatin and respirantin.

Beveridge RE, Batey RA.

Org Lett. 2014 May 2;16(9):2322-5. doi: 10.1021/ol500484f. Epub 2014 Apr 14.

PMID:
24730576
35.

Achieving the Meaningful Use Standard: A Model for Implementing Change Within Medical Practices.

Fryefield DC, Staggs S, Herman W, Stickler A, Ahmad A, Patt DA, Beveridge RA.

J Oncol Pract. 2014 Mar;10(2):105. doi: 10.1200/JOP.2013.001105.

PMID:
29452558
36.

Total synthesis of the cytotoxic enehydrazide natural products hydrazidomycins A and B by a carbazate addition/Peterson olefination approach.

Beveridge RE, Batey RA.

Org Lett. 2013 Jun 21;15(12):3086-9. doi: 10.1021/ol401275f. Epub 2013 Jun 4.

PMID:
23734814
37.

Roundtable--the changing oncology landscape: evolution or revolution?

Beveridge R, Fox J, Higgins SA, Kohn M, Mahoney JJ, Newcomer LN, von Eschenbach A, Goodman C.

J Natl Compr Canc Netw. 2013 May;11(5 Suppl):636-8.

PMID:
23704232
38.

Defining cancer care quality or delivering quality cancer care?

Brow M, Hoverman JR, Patt D, Herman B, Verrilli D, Garey J, Beveridge R.

J Natl Compr Canc Netw. 2013 Feb 1;11(2):121-4. No abstract available.

PMID:
23411378
39.

Mass spectrometry methods for intrinsically disordered proteins.

Beveridge R, Chappuis Q, Macphee C, Barran P.

Analyst. 2013 Jan 7;138(1):32-42. doi: 10.1039/c2an35665a. Review.

PMID:
23108160
40.

The centriolar satellite protein Cep131 is important for genome stability.

Staples CJ, Myers KN, Beveridge RD, Patil AA, Lee AJ, Swanton C, Howell M, Boulton SJ, Collis SJ.

J Cell Sci. 2012 Oct 15;125(Pt 20):4770-9. doi: 10.1242/jcs.104059. Epub 2012 Jul 13.

41.

Defining Value in Cancer Care: AVBCC 2012 Steering Committee Report.

AVBCC 2013 Steering Committee: Co-Moderators, Beed G, Owens GM; Steering Committee Members, Benson AB 3rd, Klein IM, Silver SM, Beveridge RA, Malin J, Sprandio JD, Deligdish CK, Mitchell M, Vogenberg FR, Fox J, Newcomer LN.

Am Health Drug Benefits. 2012 Jul;5(4):202-17.

42.

Palliative care and oncology partnerships in real practice.

Alesi ER, Fletcher D, Muir C, Beveridge R, Smith TJ.

Oncology (Williston Park). 2011 Nov 30;25(13):1287-90, 1292-3.

43.

Terminal alkyne addition to diazodicarboxylates: synthesis of hydrazide linked alkynes (ynehydrazides).

Beveridge RE, Batey RA.

Org Lett. 2012 Jan 20;14(2):540-3. doi: 10.1021/ol2031608. Epub 2012 Jan 4.

PMID:
22216967
44.

Benchmarks for value in cancer care: an analysis of a large commercial population.

Kolodziej M, Hoverman JR, Garey JS, Espirito J, Sheth S, Ginsburg A, Neubauer MA, Patt D, Brooks B, White C, Sitarik M, Anderson R, Beveridge R.

J Oncol Pract. 2011 Sep;7(5):301-6. doi: 10.1200/JOP.2011.000394.

45.

Creating a process to standardize regimen order sets within an electronic health record.

Busby LT, Sheth S, Garey J, Ginsburg A, Flynn T, Willen MA, Kruger S, Neubauer MA, Kolodziej M, Chang D, Palmer ES, McGuinness M, Egerton NJ, Merriman J, Herbeck EB, Fetter A, Frisk L, Sitarik M, Anderson R, Beveridge R.

J Oncol Pract. 2011 Jul;7(4):e8-e14. doi: 10.1200/JOP.2011.000275.

46.

Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databases.

Hoverman JR, Cartwright TH, Patt DA, Espirito JL, Clayton MP, Garey JS, Kopp TJ, Kolodziej M, Neubauer MA, Fitch K, Pyenson B, Beveridge RA.

J Oncol Pract. 2011 May;7(3 Suppl):52s-9s. doi: 10.1200/JOP.2011.000318.

47.

Economic impact of disease progression in follicular non-Hodgkin lymphoma.

Beveridge R, Satram-Hoang S, Sail K, Darragh J, Chen C, Forsyth M, Reyes C.

Leuk Lymphoma. 2011 Nov;52(11):2117-23. doi: 10.3109/10428194.2011.592623. Epub 2011 Jul 12.

48.

Pathways, outcomes, and costs in colon cancer: retrospective evaluations in 2 distinct databases.

Hoverman JR, Cartwright TH, Patt DA, Espirito JL, Clayton MP, Garey JS, Kopp TJ, Kolodziej M, Neubauer MA, Fitch K, Pyenson B, Beveridge RA.

Am J Manag Care. 2011 May;17 Suppl 5 Developing:SP45-52.

49.

Affiliation and control during marital disagreement, history of divorce, and asymptomatic coronary artery calcification in older couples.

Smith TW, Uchino BN, Florsheim P, Berg CA, Butner J, Hawkins M, Henry NJ, Beveridge RM, Pearce G, Hopkins PN, Yoon HC.

Psychosom Med. 2011 May;73(4):350-7. doi: 10.1097/PSY.0b013e31821188ca. Epub 2011 Mar 1.

50.

Perceptions of the cognitive compensation and interpersonal enjoyment functions of collaboration among middle-aged and older married couples.

Berg CA, Schindler I, Smith TW, Skinner M, Beveridge RM.

Psychol Aging. 2011 Mar;26(1):167-73. doi: 10.1037/a0021124.

PMID:
20973607

Supplemental Content

Loading ...
Support Center